Article Details

RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment

Retrieved on: 2021-02-08 16:30:00

Tags for this article:

Click the tags to see associated articles and topics

RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment. View article details on hiswai:

Excerpt

Remdesivir, an inhibitor of the viral RNA-dependent, RNA polymerase, is a direct-acting antiviral agent that is approved by the FDA as a treatment for ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up